Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
MicroStrategy
MSTR
US Stock MarketDetailed Quotes
VALN Valneva
- 3.990
- -0.360-8.28%
Close Dec 20 16:00 ET
- 3.990
- 0.0000.00%
Post 20:01 ET
323.98MMarket Cap-32.18P/E (TTM)
4.250High3.990Low53.70KVolume4.250Open4.350Pre Close222.32KTurnover0.09%Turnover RatioLossP/E (Static)81.20MShares10.76052wk High1.44P/B236.20MFloat Cap3.62052wk Low--Dividend TTM59.20MShs Float67.840Historical High--Div YieldTTM5.98%Amplitude3.620Historical Low4.139Avg Price1Lot Size
About Valneva Company
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.
Company Profile
SymbolVALN
Company NameValneva
Issue Price26.41
Founded1999
CEOMr. Thomas Lingelbach
MarketNASDAQ
Employees676
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends12-31
AddressCampus Bio-Ouest,6, rue Alain Bombard
CitySaint-Herblain
ProvinceGE
CountryFrance
Zip Code44800
Phone33-2-28-07-37-10
Websitehttp://www.valneva.com
Company Executives
- Name
- Position
- Salary
- Thomas Lingelbach
- Director, President and Chief Executive Officer
- 401.34K
- Franck Grimaud
- Chief Business Officer
- 401.34K
- Dipal Patel
- Chief Commercial Officer
- 516.75K
- Vincent Dequenne
- Chief Operating Officer
- --
- Peter Buhler
- Chief Financial Officer
- 558.83K
- Petra Pesendorfer
- Chief People Officer
- --
- Dr. Juan Carlos Jaramillo, M.D.
- Chief Medical Officer
- 539.76K
- Anne-Marie Graffin
- Chairman of the Board
- 74.30K
- James R. Sulat
- Vice Chairman of the Board
- 74.07K
- Dr. Kathrin Jansen
- Director
- 28.25K
- Mailys Ferrere
- Independent Director
- --
- James Connolly
- Independent Director
- 66.11K
- Frederic Jacotot
- General Counsel and Corporate Secretary
- 305.20K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.